37 related articles for article (PubMed ID: 16293846)
1. Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.
Wilson PM; Booth AM; Eastwood A; Watt IS
J R Soc Med; 2008 Mar; 101(3):125-32. PubMed ID: 18344469
[TBL] [Abstract][Full Text] [Related]
2. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?
Hillner BE; Smith TJ
J Clin Oncol; 2007 Feb; 25(6):611-3. PubMed ID: 17308264
[No Abstract] [Full Text] [Related]
3. Adjuvant trastuzumab for breast cancer: editorial does not mention health economics of drug.
McLaren EH
BMJ; 2005 Nov; 331(7526):1203. PubMed ID: 16293854
[No Abstract] [Full Text] [Related]
4. Adjuvant trastuzumab for breast cancer: an increasingly common ethical and economic conundrum.
Grove ML
BMJ; 2005 Nov; 331(7526):1202. PubMed ID: 16293847
[No Abstract] [Full Text] [Related]
5. Trastuzumab in breast cancer.
Mastrianni DM
N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470953
[No Abstract] [Full Text] [Related]
6. Adjuvant trastuzumab for breast cancer.
Dent R; Clemons M
BMJ; 2005 Nov; 331(7524):1035-6. PubMed ID: 16269471
[No Abstract] [Full Text] [Related]
7. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ; Procter M; Leyland-Jones B; Goldhirsch A; Untch M; Smith I; Gianni L; Baselga J; Bell R; Jackisch C; Cameron D; Dowsett M; Barrios CH; Steger G; Huang CS; Andersson M; Inbar M; Lichinitser M; Láng I; Nitz U; Iwata H; Thomssen C; Lohrisch C; Suter TM; Rüschoff J; Suto T; Greatorex V; Ward C; Straehle C; McFadden E; Dolci MS; Gelber RD;
N Engl J Med; 2005 Oct; 353(16):1659-72. PubMed ID: 16236737
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant trastuzumab for breast cancer: the other side of the coin.
Gopalakrishnan S; Linnane J
BMJ; 2005 Nov; 331(7526):1202-3. PubMed ID: 16293846
[No Abstract] [Full Text] [Related]
9. How much will Herceptin really cost?
Barrett A; Roques T; Small M; Smith RD
BMJ; 2006 Nov; 333(7578):1118-20. PubMed ID: 17124225
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab for early breast cancer: current status and future directions.
Dinh P; de Azambuja E; Piccart-Gebhart MJ
Clin Adv Hematol Oncol; 2007 Sep; 5(9):707-17. PubMed ID: 17982412
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
